Clearmind Medicine Inc. Selling, General and Administrative Expense
Clearmind Medicine Inc. (CMND) reported Selling, General and Administrative Expense of $4.36 million for the 12-month period ending 2024-10-31, per its 20-F filed 2025-01-22.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:SellingGeneralAndAdministrativeExpense · last filed 2025-01-22
| Period end | Selling General And Administrative Expense 12 month |
|---|---|
| 2024-10-31 | $4.36M 20-F · filed 2025-01-22 |
| 2023-10-31 | $4.76M 20-F · filed 2025-01-22 |
| 2022-10-31 | $3.17M 20-F · filed 2025-01-22 |
| 2021-10-31 | $2.22M 20-F/A · filed 2024-03-18 |